Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1992 Apr;156(4):380–384.

Acute poisoning from gamma-hydroxybutyrate in California.

M Y Chin 1, R A Kreutzer 1, J E Dyer 1
PMCID: PMC1003276  PMID: 1574880

Abstract

We report a series of 5 representative patients in California who experienced adverse reactions from the illicitly marketed substance gamma-hydroxybutyrate (GHB). The drug is a putative neurotransmitter marketed as a growth hormone releaser for bodybuilders. The most commonly reported symptoms included abrupt drowsiness, dizziness, and a "high". Other effects were headache, nausea, vomiting, myoclonic jerking, and short-term coma. There have been no reported deaths. If product use is discontinued, full recovery with no long-term side effects is universal. No clear dose-response effect was observed; this may be attributable to differences in susceptibility, wide variations in doses taken by the same person, or the coingestion of other substances. Case interviews confirm that, despite being banned by the US Food and Drug Administration, GHB is still widely available in the underground drug market. Athletes and bodybuilders may take drugs for which there are claims of improved performance or body image. Physicians should be alert for signs of GHB poisoning in emergency department and clinic patients.

Full text

PDF
382

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appleton P. J., Burn J. M. A neuroinhibitory substance: gamma hydroxybutyric acid. Preliminary report of first clinical trial in Britain. Anesth Analg. 1968 Mar-Apr;47(2):164–170. [PubMed] [Google Scholar]
  2. Buckley W. E., Yesalis C. E., 3rd, Friedl K. E., Anderson W. A., Streit A. L., Wright J. E. Estimated prevalence of anabolic steroid use among male high school seniors. JAMA. 1988 Dec 16;260(23):3441–3445. [PubMed] [Google Scholar]
  3. Dyer J. E. gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity. Am J Emerg Med. 1991 Jul;9(4):321–324. doi: 10.1016/0735-6757(91)90050-t. [DOI] [PubMed] [Google Scholar]
  4. Kaufman E. E., Nelson T., Goochee C., Sokoloff L. Purification and characterization of an NADP+-linked alcohol oxido-reductase which catalyzes the interconversion of gamma-hydroxybutyrate and succinic semialdehyde. J Neurochem. 1979 Mar;32(3):699–712. doi: 10.1111/j.1471-4159.1979.tb04552.x. [DOI] [PubMed] [Google Scholar]
  5. Lapierre O., Montplaisir J., Lamarre M., Bedard M. A. The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms. Sleep. 1990 Feb;13(1):24–30. doi: 10.1093/sleep/13.1.24. [DOI] [PubMed] [Google Scholar]
  6. Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev. 1989 Winter;13(4):187–198. doi: 10.1016/s0149-7634(89)80053-3. [DOI] [PubMed] [Google Scholar]
  7. Mandel P., Maitre M., Vayer P., Hechler V. Function of gamma-hydroxybutyrate: a putative neurotransmitter. Biochem Soc Trans. 1987 Apr;15(2):215–217. doi: 10.1042/bst0150215. [DOI] [PubMed] [Google Scholar]
  8. McCabe E. R., Layne E. C., Sayler D. F., Slusher N., Bessman S. P. ynergy of ethanol and a natural soporific--gamma hydroxybutyrate. Science. 1971 Jan 29;171(3969):404–406. doi: 10.1126/science.171.3969.404. [DOI] [PubMed] [Google Scholar]
  9. Moore W. V. Anabolic steroid use in adolescence. JAMA. 1988 Dec 16;260(23):3484–3486. [PubMed] [Google Scholar]
  10. Nelson T., Kaufman E., Kline J., Sokoloff L. The extraneural distribution of gamma-hydroxybutyrate. J Neurochem. 1981 Nov;37(5):1345–1348. doi: 10.1111/j.1471-4159.1981.tb04689.x. [DOI] [PubMed] [Google Scholar]
  11. Roth R. H. Striatal dopamine and gamma-hydroxybutyrate. Pharmacol Ther B. 1976;2(1):71–88. doi: 10.1016/0306-039x(76)90020-9. [DOI] [PubMed] [Google Scholar]
  12. Snead O. C., 3rd, Liu C. C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol. 1984 Aug 15;33(16):2587–2590. doi: 10.1016/0006-2952(84)90629-4. [DOI] [PubMed] [Google Scholar]
  13. Takahara J., Yunoki S., Yakushiji W., Yamauchi J., Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab. 1977 May;44(5):1014–1017. doi: 10.1210/jcem-44-5-1014. [DOI] [PubMed] [Google Scholar]
  14. Vickers M. D. Gamma hydroxybutyric acid. Clinical pharmacology and current status. Proc R Soc Med. 1968 Aug;61(8):821–824. [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES